IDEAYA Biosciences, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 260,261 | $4,263,075 | 0.31% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 2, 2025 |
| June 30, 2025 | 260,261 | $5,470,686 | 0.35% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 1, 2025 |
| Sept. 30, 2025 | 280,261 | $7,625,902 | 0.44% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 31, 2025 |
| Dec. 31, 2025 | 280,261 | $9,688,623 | 0.55% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 280,261 | $9,338,297 | 0.61% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 308,240 | $11,488,105 | 0.68% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 31, 2026 |
| Sept. 30, 2026 | 308,240 | $11,842,581 | 0.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.